Ceesay Abraham
Chief Executive Officer
Ceesay Abraham has filed 17 SEC Form 4 filings (46 transaction rows) across 2 companies, including RAPP, CRL, with disclosures dating back to 2025. 14 of those filings fall inside the rolling window. Most recent filing: Oct 23, 2026.
On the most recent filing, Ceesay Abraham is listed as Chief Executive Officer at Rapport Therapeutics, Inc. Inside the rolling window, Ceesay Abraham reported no open-market purchases and 15 open-market sales totaling $6.0M in RAPP. The largest disclosed transaction in the window is a sale of 28,958 RAPP shares on Aug 11, 2026, worth $1.4M.
Companies traded
Other insiders at RAPP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.0M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| RAPP | Chief Executive Officer | Sale | 2,210 | $64K | Oct 23 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 3,375 | $108K | Oct 8 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 1,147 | $35K | Oct 8 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 2,210 | $87K | Sep 24 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 8,210 | $374K | Sep 9 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 18,921 | $938K | Aug 26 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 22,541 | $1.0M | Aug 12 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 28,958 | $1.4M | Aug 12 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 2,210 | $93K | Jul 29 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 8,210 | $328K | Jul 15 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 8,220 | $327K | Jul 1 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 10,916 | $320K | Feb 19 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 10,916 | $285K | Jan 22 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 10,916 | $324K | Dec 18 | SEC ↗ | |
| RAPP | Chief Executive Officer | Sale | 10,916 | $275K | Nov 18 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 15, 2025 | RAPP | Sale | $20K |
| Oct 15, 2025 | RAPP | Sale | $111K |
| Oct 15, 2025 | RAPP | Sale | $31K |
| Oct 15, 2025 | RAPP | Sale | $120K |
| Sep 17, 2025 | RAPP | Sale | $19K |
| Sep 17, 2025 | RAPP | Sale | $918K |
| Sep 17, 2025 | RAPP | Sale | $38K |
| Sep 17, 2025 | RAPP | Sale | $1.0M |
| Sep 4, 2025 | PCRX | Sale | $64K |
Frequently asked questions
How many SEC Form 4 filings has Ceesay Abraham made?
Ceesay Abraham has filed 17 SEC Form 4 filings (46 transaction rows) across 2 companies, including RAPP, CRL since 2025.
Which companies does Ceesay Abraham trade?
Ceesay Abraham has filed SEC Form 4 disclosures for 2 companies, including RAPP, CRL.
When was Ceesay Abraham's most recent SEC Form 4 filing?
Ceesay Abraham's most recent SEC Form 4 filing on Tracefour is dated Oct 23, 2026.
What is Ceesay Abraham's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ceesay Abraham is listed as Chief Executive Officer.
What is Ceesay Abraham's total buy and sell value in the current window?
Inside the rolling retention window, Ceesay Abraham bought $0 and sold $6.0M based on SEC Form 4 filings.
What was Ceesay Abraham's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 28,958 RAPP shares on 2026-08-11, worth $1.4M, per SEC Form 4 filings.